Arbutus Biopharma Corp (ABUS)
Q3 2018 Earnings Conference Call
November 7, 2018 04:30 pm ET
Executives
Pam Murphy - IR
Mark Murray - President and CEO
Mike Sofia - CSO
David Hastings - CFO
Analysts
Liisa Bayko - JMP Securities
Katherine Xu - William Blair
Keay Nakae - Chardan
Presentation
Operator
Good day, ladies and gentlemen, and welcome to Arbutus Biopharma Corporation 2018 Third Quarter Financial Results and Corporate Update. [Operator Instructions] As a reminder this conference is being recorded.
I'd now like to introduce your host for today's conference. Ms. Pam Murphy, you may